Refractive And Visual Outcomes Of Immediate Bilateral Implantation Of A Novel Pentafocal Intraocular Lens
Published 2025 - 43rd Congress of the ESCRS
Reference: PO407 | Type: Free paper | DOI: 10.82333/4rpf-ry31
Authors: James Thomas 1 , Helen Burn* 2 , Rebecca Turner 2 , Kikkeri Arun 3 , Rory McKinnon 4 , Louisa Stacey 4 , Ernest Lim 5 , Kanmin Xue 6 , Natalia Wojtowicz 7 , Richard Lee 7 , Christina Sothinathan 7 , Evgenia Anikina 8 , Christopher King 3 , Sarah Maling 3 , Mehmet Cubuk 3 , Nick de Pennington 4 , Aisling Higham 9
1Nuffield Department of Clinical Neurosciences,Oxford University,Oxford,United Kingdom;Ufonia Limited,Oxford,United Kingdom, 2Ophthalmology,Oxford University Hospitals NHS Foundation Trust,Oxford,United Kingdom, 3Ophthalmology,Buckinghamshire Healthcare NHS Trust,Buckinghamshire,United Kingdom, 4Ufonia Limited,Oxford,United Kingdom, 5Ufonia Limited,Oxford,United Kingdom;Ophthalmology,Moorfields Eye Hospital,London,United Kingdom;Computer Science,University of York,York,United Kingdom, 6NUFFIELD DEPARTMENT OF CLINICAL NEUROSCIENCES,Oxford University,Oxford,United Kingdom;Ophthalmology,Oxford University Hospitals NHS Foundation Trust,Oxford,United Kingdom, 7Ophthalmology,Chelsea and Westminster Hospital,London,United Kingdom, 8Ophthalmology,Royal Berkshire Hospital ,Reading,United Kingdom, 9Ufonia Limited,Oxford,United Kingdom;Ophthalmology,Moorfields Eye Hospital,London,United Kingdom
Purpose
To evaluate the refractive and visual outcomes following immediate sequential bilateral implantation of the innovative pentafocal Intensity IOL (intraocular lens).
Setting
Private refractive surgery clinic, The Netherlands
Methods
60 patients (120 eyes) of an average age of 54 years were included who underwent bilateral IOL implantation from February 2022 to July 2023. Fifty-four eyes were implanted with a spherical and 66 with a toric IOL, respectively. We evaluated visual and refractive outcomes, including the gain and loss of lines, percentage of patients within 0.25 D, 0.5 D, and 1.0 D of emmetropia, patient satisfaction, halos, and complications.
Results
The mean postoperative uncorrected visual acuity -0.006 logMAR was significantly better than preoperative uncorrected visual acuity (p<0.001). The mean preoperative cylinder (-0.62D) was significantly higher than the mean postoperative cylinder (-0.11D) (p<0.001). 94% of the eyes stayed constant or gained a row of vision compared to pre-operative corrected distance visual acuity. In eyes with measured intermediate vision post-operatively uncorrected intermediate visual acuity was 0 LogMAR or better. Postoperatively, 90%, 96% and 99% of patients were within ±0.5 D, ±0.75 D and ±1 D of emmetropia, respectively. There were no major postoperative complications, and patient satisfaction was high (n=119). 99.2% reported spectacle independence.
Conclusions
The new pentafocal IOL provides good visual outcomes over a wide range of distances, particularly for intermediate vision, a high rate of spectacle freedom, with a low incidence of ocular side effects.